menu
    • menu

    Company profile for Arvinas

    NEW Drugs in Dev: 7
    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Sigma-Aldrich empowers scientific discovery with top-quality solutions to accelerate research, innovation, and better health worldwide.

    Virtual Booth

    Contact Supplier

    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Arvinas is a pharmaceutical company focused on developing new small molecules ‒ known as PROTACs (PROteolysis TArgeting Chimeras) ‒ aimed at degrading disease-causing cellular proteins via proteolysis. Based on innovative research conducted at Yale University by Dr. Craig Crews, Founder and Chief Scientific Advisor, the company is translating natural protein degradation approaches into novel drugs for the treatment of canc...
    Arvinas is a pharmaceutical company focused on developing new small molecules ‒ known as PROTACs (PROteolysis TArgeting Chimeras) ‒ aimed at degrading disease-causing cellular proteins via proteolysis. Based on innovative research conducted at Yale University by Dr. Craig Crews, Founder and Chief Scientific Advisor, the company is translating natural protein degradation approaches into novel drugs for the treatment of cancer and other diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ArvinasUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    5 Science Park 395 Winchester Ave. New Haven, CT 06511
    Telephone
    Telephone
    +1.203.535.1456
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.arvinas.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/arvinas/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Arvinas Joins MJFF Program to Advance LRRK2 Parkinson's Therapies
    Arvinas Joins MJFF Program to Advance LRRK2 Parkinson's Therapies

    04 Jun 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/06/04/3306679/0/en/arvinas-joins-the-michael-j-fox-foundation-s-lite-and-ppmi-programs-to-advance-new-therapies-targeting-lrrk2-for-parkinson-s-disease.html

    GLOBENEWSWIRE
    04 Jun 2026
    Share Share
    Arvinas To Present At Jefferies Global Healthcare Conference
    Arvinas To Present At Jefferies Global Healthcare Conference

    29 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/29/3303805/0/en/arvinas-to-present-at-jefferies-global-healthcare-conference.html

    GLOBENEWSWIRE
    29 May 2026
    Share Share
    Arvinas Employees Give Back During Company-Wide Impact Day
    Arvinas Employees Give Back During Company-Wide Impact Day

    18 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/18/3296793/0/en/arvinas-employees-give-back-during-company-wide-impact-day.html

    GLOBENEWSWIRE
    18 May 2026
    Share Share
    Pfizer And Arvinas Give Disappointing Breast Cancer Drug To Rigel
    Pfizer And Arvinas Give Disappointing Breast Cancer Drug To Rigel

    12 May 2026

    // ENDPOINTS

    https://endpoints.news/pfizer-and-arvinas-give-disappointing-breast-cancer-drug-to-rigel/

    ENDPOINTS
    12 May 2026
    Share Share
    Arvinas Reports Q1 2026 Financials And Corporate Update
    Arvinas Reports Q1 2026 Financials And Corporate Update

    12 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/12/3292695/0/en/arvinas-reports-first-quarter-2026-financial-results-and-provides-corporate-update.html

    GLOBENEWSWIRE
    12 May 2026
    Share Share
    Arvinas To Release Q1 2026 Financial Results On May 12
    Arvinas To Release Q1 2026 Financial Results On May 12

    05 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/05/3287471/0/en/arvinas-to-report-first-quarter-2026-financial-results-on-may-12-2026.html

    GLOBENEWSWIRE
    05 May 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search